Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
Abstract:
The invention relates to methods of treating stress-sensitive psychiatric diseases arising from trauma in a subject by enhancing ghrelin signaling in the BLA of the subject. The invention also relates to methods of reversing ghrelin resistance.
Information query
Patent Agency Ranking
0/0